Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) Valuation

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, acc...

Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) currently trades at a P/E ratio of 14.01 (historical range: 13.39–14.43, median: 13.74), placing it at the 62th percentile — above its historical average, P/S ratio of 2.34 (range: 2.24–2.41, 62th percentile — above its historical average), EV/EBITDA of 19.25 (range: 18.49–19.77, 62th percentile).

Sanofi American Depositary Shares (Each representing one-half of one ordinary share) appears slightly overvalued relative to its historical range, with most valuation metrics above their median levels.